DE60234717D1 - Verwendung von calmodulin zur förderung der knochenregeneration - Google Patents

Verwendung von calmodulin zur förderung der knochenregeneration

Info

Publication number
DE60234717D1
DE60234717D1 DE60234717T DE60234717T DE60234717D1 DE 60234717 D1 DE60234717 D1 DE 60234717D1 DE 60234717 T DE60234717 T DE 60234717T DE 60234717 T DE60234717 T DE 60234717T DE 60234717 D1 DE60234717 D1 DE 60234717D1
Authority
DE
Germany
Prior art keywords
calmodulin
bone regeneration
promote bone
promote
regeneration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60234717T
Other languages
English (en)
Inventor
John Mcmichael
Harry C Gurney
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Milkhaus Laboratory Inc
Original Assignee
Milkhaus Laboratory Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Milkhaus Laboratory Inc filed Critical Milkhaus Laboratory Inc
Application granted granted Critical
Publication of DE60234717D1 publication Critical patent/DE60234717D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Feed For Specific Animals (AREA)
DE60234717T 2002-01-16 2002-12-27 Verwendung von calmodulin zur förderung der knochenregeneration Expired - Lifetime DE60234717D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34916302P 2002-01-16 2002-01-16
PCT/US2002/041440 WO2003061565A2 (en) 2002-01-16 2002-12-27 Use of calmodulin to promote bone regeneration

Publications (1)

Publication Number Publication Date
DE60234717D1 true DE60234717D1 (de) 2010-01-21

Family

ID=34192901

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60234717T Expired - Lifetime DE60234717D1 (de) 2002-01-16 2002-12-27 Verwendung von calmodulin zur förderung der knochenregeneration

Country Status (7)

Country Link
US (1) US6989368B2 (de)
EP (1) EP1472282B1 (de)
JP (1) JP4652689B2 (de)
AU (1) AU2002360785B2 (de)
CA (1) CA2473694C (de)
DE (1) DE60234717D1 (de)
WO (1) WO2003061565A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040266689A1 (en) * 2002-01-16 2004-12-30 Mcmichael John Use of calmodulin to promote bone regeneration
US20050032701A1 (en) * 2002-01-16 2005-02-10 Milkhaus Laboratory Inc. Use of calmodulin to promote bone regeneration
US20050171015A1 (en) * 2003-10-31 2005-08-04 Crabtree Gerald R. Methods and agents for enhancing bone formation or preventing bone loss
EP2311953A1 (de) * 2004-08-04 2011-04-20 Riken Knochen-/Gelenkerkrankungsempfänglichkeitsgen und Verwendung davon
WO2008114082A1 (en) * 2007-03-21 2008-09-25 Dorr Felt Tippens Methods, processes and compositions comprising the protein calmodulin (cam) for treatment of damaged or ageing skin, and/or hair loss
TWI405598B (zh) * 2009-08-24 2013-08-21 Nat Applied Res Laboratories 利用遠紅外線釋放物質增加攜鈣蛋白之方法
KR20160056941A (ko) 2013-09-25 2016-05-20 프로뉴트리아 바이오사이언시스, 인코퍼레이티드 당뇨병 및 비만의 예방 및 치료를 위한 조성물 및 제형, 그리고 글루코스 및 열량 제어에서 이들의 생성방법 및 용도

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5686116A (en) * 1990-01-12 1997-11-11 New York Society For The Relief Of The Ruptured And Crippled, Maintaining The Hospital For Special Surgery Methods of enhancing repair, healing and augmentation of bone implants
US5695518A (en) * 1990-12-28 1997-12-09 Laerum; Frode Filtering device for preventing embolism and/or distension of blood vessel walls
US5698518A (en) * 1994-03-30 1997-12-16 Oklahoma Medical Research Foundation Method for regulating inflammation and tumor growth with calmodulin, calmodulin analogues or calmodulin antagonists
US6190893B1 (en) * 1998-09-18 2001-02-20 Massachusetts Institute Of Technology Electroactive materials for stimulation of biological activity of bone marrow stromal cells

Also Published As

Publication number Publication date
CA2473694A1 (en) 2003-07-31
JP4652689B2 (ja) 2011-03-16
EP1472282B1 (de) 2009-12-09
WO2003061565A2 (en) 2003-07-31
EP1472282A4 (de) 2007-06-27
CA2473694C (en) 2012-06-19
US20030232751A1 (en) 2003-12-18
WO2003061565A3 (en) 2003-11-20
EP1472282A2 (de) 2004-11-03
JP2005520810A (ja) 2005-07-14
AU2002360785B2 (en) 2008-09-18
US6989368B2 (en) 2006-01-24

Similar Documents

Publication Publication Date Title
DE60321130D1 (de) Variation von parametern zur neurostimulation
ATE329987T1 (de) Verwendung von fischer-tropsch/crackfraktion- gemischen zur erzielung niedriger emissionen
ATE419856T1 (de) Verwendung von rimexolon zur behandlung von augentrockenheit
DE502005006470D1 (de) Verwendung von sulfonylharnstoffen
DE60326874D1 (de) Neue verwendung von erythropoietin in herzerkrankungen
DE60311379D1 (de) Körperverträgliches Stützgerüst zur Wiederherstellung von Bändern oder Sehnen
DE60311806D1 (de) Klammer zur Befestigung von Hernia-Netz
ATE501125T1 (de) Verfahren zur herstellung des calciumsalzes von rosuvastatin
ATE357440T1 (de) Benzodiazepin-substituierte piperdine zur verwendung in der behandlung von cardiovaskulären erkrankungen
ATE510556T1 (de) Verwendung von erythropoietin
DE50107445D1 (de) Verwendung von polyesteramiden zur stabilisierung von asphaltenen in rohöl
DE60335018D1 (de) Mittel zur verhinderung von hautalterung
DE60322898D1 (de) Verwendung von isoflavonen zur förderung des schlankheitseffekts
DE60325967D1 (de) Stimulierung von hämatopoiese bei ex vivo aktivierten immunzellen
DE60130661D1 (de) Verwendung der 13-cis retinsäure zur behandlung von emphysemen
DE60235282D1 (de) Verwendung von verdrängtem syngas zur regeneration von scr-katalysator
DE60317693D1 (de) Methode und verwendung von thermostabilen rna-ligasen
DE60234717D1 (de) Verwendung von calmodulin zur förderung der knochenregeneration
ATE418337T1 (de) Verwendung von dihydroimidazolonen zur behandlung von epilepsie bei hunden
ATE404203T1 (de) Verwendung von desoxypeganin zur behandlung der klinischen depression
ATE319668T1 (de) Verfahren zur synthese von (2s)-indolin-2- carbonsäure, und verwendung in der synthese von perindopril
ATE376416T1 (de) Verwendung von ambroxol zur behandlung von chronischen schmerzen
DE60216986D1 (de) Neue verwendung von pipatalin
DE602004004293D1 (de) Verfahren zur isomerisierung von metallocenverbindungen
DE60103016D1 (de) Verwendung von alpha interferon zur behandlung von ewings sarcom

Legal Events

Date Code Title Description
8364 No opposition during term of opposition